Reading Time: 2 minutes Chicago | Reuters — A federal judge has temporarily blocked California’s plans to require cancer warnings on products containing glyphosate, in a win for manufacturer Monsanto. U.S. District Judge William Shubb said the warnings would be misleading because glyphosate is not known to cause cancer, according to court documents filed on Monday in California. He […] Read more
U.S. judge halts California plan for warnings on glyphosate
France says will not ban glyphosate when no alternative
Reading Time: < 1 minute Saint-Genes-Champanelle, France | Reuters — France will not force farmers to stop using glyphosate after a ban planned within three years, in cases where an alternative has not been found, President Emmanuel Macron said on Thursday. He added that this would likely concern 10 per cent of farms while solutions could be found for the […] Read more
EU delays decision on glyphosate
Reading Time: 2 minutes Brussels | Reuters — EU countries failed on Wednesday to vote on a licence extension for glyphosate, delaying again a decision on the widely used herbicide that critics say could cause cancer. The European Commission said in a statement the relevant committee did not hold a vote at a meeting and that it would announce […] Read more
France open to phasing out glyphosate
Reading Time: 2 minutes Paris | Reuters — France is open to phasing out common weedkiller glyphosate, the government said on Monday, following complaints from farmers worried about a potential imminent ban. Prime Minister Edouard Philippe reiterated Paris would vote against the European Commission’s proposal to extend for 10 years the licence for glyphosate, which is used in Monsanto’s […] Read more
EU to propose 10-year licence renewal for glyphosate
Reading Time: 2 minutes Brussels | Reuters — The European Commission will propose extending by 10 years its approval for glyphosate, the active ingredient in Monsanto’s Roundup herbicide, a spokeswoman said on Wednesday. A transatlantic row over possible risks to human health has prompted investigations by congressional committees in the U.S., and in Europe has forced a delay to […] Read more
Glyphosate clears Health Canada re-evaluation
Reading Time: 2 minutes Crop protection companies selling glyphosate have two years to make minor changes to parts of their product labels, as the 43-year-old herbicide formally clears Health Canada’s re-evaluation process. The re-evaluation, launched in late 2009 in a standard federal practice for registered pesticides in Canada, has ruled that products containing glyphosate — when used following the […] Read more
New study on glyphosate to feed into crucial EU vote
Reading Time: 3 minutes London | Reuters — Results of a new animal study into possible health risks of glyphosate will be published in time to inform a key EU re-licensing vote due by the end of 2017, according to the researcher leading the trial. A row over possible effects of glyphosate — an ingredient in Monsanto’s herbicide Roundup […] Read more
EU chemical agency says glyphosate not carcinogenic
Reading Time: 2 minutes Helsinki | Reuters — Glyphosate, the key ingredient in Monsanto’s Roundup herbicide, should not be classified as a substance causing cancer, the European Chemical Agency concluded on Wednesday, potentially paving the way for its licence renewal in the EU. A transatlantic row over possible risks to human health has prompted investigations by congressional committees in […] Read more
EPA approves Monsanto’s dicamba weed killer
Reading Time: < 1 minute U.S. seeds and agrochemicals maker Monsanto Co. has secured approval from the U.S. Environmental Protection Agency for a new dicamba-based weed killer designed for its next generation biotech soy and cotton varieties, the company said on Wednesday. While approval had been expected, it is seen as a major step forward for the company’s newest herbicide […] Read more
WHO cancer agency asked experts to withhold glyphosate documents
Reading Time: 4 minutes London | Reuters — The World Health Organization’s cancer agency — which is facing criticism over how it classifies carcinogens — advised academic experts on one of its review panels not to disclose documents they were asked to release under U.S. freedom of information laws. In a letter and an email seen by Reuters, officials […] Read more
A message from April Stewart, Country Guide's Associate Editor
